The Biden administration is seeking input on whether to require insurers to cover over-the-counter preventive care services and treatments that don’t require a prescription, a category that encompasses birth control, smoking cessation products, and Covid-19 tests.
“Most plans and issuers currently do not cover OTC preventive products without a prescription by a health care provider. Therefore, the Departments are issuing this RFI to solicit information that will improve the Departments’ understanding of the issues related to consumer access to OTC preventive products without cost sharing and without a prescription by a health care provider,” the administration said Tuesday in its ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
